OBJECTIVE: We sought to determine whether retinopathy of prematurity (ROP) can be evaluated and managed telemedically. DESIGN: Multicenter noncomparative case series. PARTICIPANTS: Ten patients (19 eyes) with ROP were evaluated and treated per standard of care and imaged with the RetCam 120 digital fundus camera (Massie Research Laboratories, Inc., Dublin, CA). INTERVENTION: Images were transmitted to a remote site for evaluation and management recommendations. MAIN OUTCOME MEASURES: Telemedical evaluations and management recommendations were compared with traditional on-site standard of care evaluations and treatments. RESULTS: The identification of Plus disease at the remote site was accurately identified in 95% of eyes. Prethreshold, threshold, and stage 4 or 5 ROP were correctly detected in 17 of 19 (89%) eyes. CONCLUSIONS: Results indicate ROP can be evaluated and treatment recommendations made at remote sites with telemedicine strategies.
OBJECTIVE: We sought to determine whether retinopathy of prematurity (ROP) can be evaluated and managed telemedically. DESIGN: Multicenter noncomparative case series. PARTICIPANTS: Ten patients (19 eyes) with ROP were evaluated and treated per standard of care and imaged with the RetCam 120 digital fundus camera (Massie Research Laboratories, Inc., Dublin, CA). INTERVENTION: Images were transmitted to a remote site for evaluation and management recommendations. MAIN OUTCOME MEASURES: Telemedical evaluations and management recommendations were compared with traditional on-site standard of care evaluations and treatments. RESULTS: The identification of Plus disease at the remote site was accurately identified in 95% of eyes. Prethreshold, threshold, and stage 4 or 5 ROP were correctly detected in 17 of 19 (89%) eyes. CONCLUSIONS: Results indicate ROP can be evaluated and treatment recommendations made at remote sites with telemedicine strategies.
Authors: Samuel K Houston; Charles C Wykoff; Audina M Berrocal; Ditte J Hess; Timothy G Murray Journal: Lasers Med Sci Date: 2011-12-02 Impact factor: 3.161
Authors: Michael F Chiang; Michele Melia; Angela N Buffenn; Scott R Lambert; Franco M Recchia; Jennifer L Simpson; Michael B Yang Journal: Ophthalmology Date: 2012-04-27 Impact factor: 12.079
Authors: Michael F Chiang; Jeremy D Keenan; Yunling E Du; William Schiff; Gaetano Barile; Joan Li; Ditte J Hess; Rose Anne Johnson; John T Flynn; Justin Starren Journal: AMIA Annu Symp Proc Date: 2005
Authors: M F Chiang; J Starren; Y E Du; J D Keenan; W M Schiff; G R Barile; J Li; R A Johnson; D J Hess; J T Flynn Journal: Br J Ophthalmol Date: 2006-04-13 Impact factor: 4.638
Authors: Danny H Kauffinann Jokl; Ronald H Silverman; Sheri L Nemerofiky; Steven A Kane; Michael F Chiang; Robert Lopez; Grace Lee Journal: J Pediatr Ophthalmol Strabismus Date: 2006 Jan-Feb Impact factor: 1.402
Authors: Miles F Greenwald; Ian D Danford; Malika Shahrawat; Susan Ostmo; James Brown; Jayashree Kalpathy-Cramer; Kacy Bradshaw; Robert Schelonka; Howard S Cohen; R V Paul Chan; Michael F Chiang; J Peter Campbell Journal: J AAPOS Date: 2020-04-11 Impact factor: 1.220